ctrl K

MBX Biosciences Inc. Comm... (MBX)

NASDAQ: MBX · Real-Time Price · USD

11.26

0.77 (7.34%)

At close: May 01, 2025, 3:59 PM

10.60

-5.86%

Pre-market: May 02, 2025, 04:44 AM EDT

MBX Biosciences Common Stock Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Revenue	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a
Operating Income	-68.19M	-35.31M	-25.16M
Interest Income	6.27M	2.75M	372K
Pretax Income	-61.92M	-32.56M	-26.14M
Net Income	-61.92M	-32.56M	-26.14M
Selling & General & Admin	10.78M	6.78M	3.76M
Research & Development	57.41M	28.53M	21.4M
Other Expenses	n/a	n/a	n/a
Operating Expenses	68.19M	35.31M	25.16M
Interest Expense	n/a	n/a	374K
Selling & Marketing Expenses	n/a	n/a	n/a
Cost & Expenses	68.19M	35.31M	25.16M
Income Tax Expense	n/a	n/a	n/a
Shares Outstanding (Basic)	33.39M	31.85M	31.85M
Shares Outstanding (Diluted)	33.39M	31.85M	31.85M
EPS (Basic)	n/a	-1.02	-0.82
EPS (Diluted)	n/a	-1.02	-0.82
EBITDA	-67.95M	-35.15M	-25.7M
EBIT	-68.19M	-35.31M	-25.76M
Depreciation & Amortization	244K	157K	56K